Probiotics for induction of remission in ulcerative colitis (Q24242963)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Probiotics for induction of remission in ulcerative colitis (English)

0 references

0 references

1 reference

Peter T Mallon

1

0 references

Damian McKay

series ordinal

2

0 references

Steven J Kirk

series ordinal

3

0 references

Keith Gardiner

series ordinal

4

0 references

publication date

17 October 2007

0 references

published in

0 references

cites work

Effects of probiotic on intestinal mucosa of patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005573.PUB2

Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005573.PUB2

Probiotics in man and animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005573.PUB2

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005573.PUB2

7 January 2021

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005573.PUB2

7 January 2021

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005573.PUB2

7 January 2021

Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005573.PUB2

7 January 2021

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005573.PUB2

7 January 2021

Pouchitis prevention with probiotics.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005573.PUB2

7 January 2021

A pilot trial of Saccharomyces boulardii in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005573.PUB2

7 January 2021

Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005573.PUB2

7 January 2021

Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005573.PUB2

7 January 2021

Prevention of radiation-induced diarrhea with the use of VSL#3, a new high-potency probiotic preparation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005573.PUB2

7 January 2021

VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005573.PUB2

7 January 2021

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005573.PUB2

7 January 2021

Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005573.PUB2

7 January 2021

Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005573.PUB2

7 January 2021

The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005573.PUB2

7 January 2021

Immune System Stimulation by Probiotics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005573.PUB2

7 January 2021